These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

605 related items for PubMed ID: 17300567

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration.
    Augustin AJ, Schmidt-Erfurth U.
    Ophthalmology; 2006 Jan; 113(1):14-22. PubMed ID: 16360209
    [Abstract] [Full Text] [Related]

  • 24. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: meta-analysis of 2-year safety results in three randomized clinical trials: Treatment Of Age-Related Macular Degeneration With Photodynamic Therapy and Verteporfin In Photodynamic Therapy Study Report no. 4.
    Azab M, Benchaboune M, Blinder KJ, Bressler NM, Bressler SB, Gragoudas ES, Fish GE, Hao Y, Haynes L, Lim JI, Menchini U, Miller JW, Mones J, Potter MJ, Reaves A, Rosenfeld PJ, Strong A, Su XY, Slakter JS, Schmidt-Erfurth U, Sorenson JA, Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group, Verteporfin in Photodynamic Therapy (VIP) Study Group.
    Retina; 2004 Feb; 24(1):1-12. PubMed ID: 15076937
    [Abstract] [Full Text] [Related]

  • 25. Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin: fluorescein angiographic guidelines for evaluation and treatment--TAP and VIP report No. 2.
    Barbazetto I, Burdan A, Bressler NM, Bressler SB, Haynes L, Kapetanios AD, Lukas J, Olsen K, Potter M, Reaves A, Rosenfeld P, Schachat AP, Strong HA, Wenkstern A, Treatment of Age-Related Macular Degeneration with Photodynamic Therapy Study Group, Verteporfin in Photodynamic Therapy Study Group.
    Arch Ophthalmol; 2003 Sep; 121(9):1253-68. PubMed ID: 12963608
    [Abstract] [Full Text] [Related]

  • 26. Photodynamic therapy in practice: a review of the results of the first 12 months experience with verteporfin at the Royal Victorian Eye and Ear Hospital.
    Essex RW, Qureshi SH, Cain MS, Harper CA, Guymer RH.
    Clin Exp Ophthalmol; 2003 Dec; 31(6):476-81. PubMed ID: 14641153
    [Abstract] [Full Text] [Related]

  • 27. 12-month retrospective study and review of photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in age-related macular degeneration.
    Incorvaia C, Campa C, Parmeggiani F, Menzione M, D'Angelo S, Della Corte M, Rinaldi M, Romano M, Dell'omo R, Costagliola C.
    Retina; 2008 Feb; 28(2):289-97. PubMed ID: 18301052
    [Abstract] [Full Text] [Related]

  • 28. Photodynamic therapy with intravitreal triamcinolone in predominantly classic choroidal neovascularization: one-year results of a randomized study.
    Arias L, Garcia-Arumi J, Ramon JM, Badia M, Rubio M, Pujol O.
    Ophthalmology; 2006 Dec; 113(12):2243-50. PubMed ID: 16996600
    [Abstract] [Full Text] [Related]

  • 29. Japanese age-related macular degeneration trial: 1-year results of photodynamic therapy with verteporfin in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration.
    Japanese Age-Related Macular Degeneration Tial (JAT) Study Group.
    Am J Ophthalmol; 2003 Dec; 136(6):1049-61. PubMed ID: 14644215
    [Abstract] [Full Text] [Related]

  • 30. [Clinical trial of verteporfin photodynamic therapy in Chinese age-related macular degeneration with subfoveal predominant choroidal neovascularization patients].
    Chen YX, Ge J, Yan M, Jin CJ, Zhang MX, Dong FT, Lu F, Zhang CF, Zhao JL.
    Zhonghua Yan Ke Za Zhi; 2007 Mar; 43(3):198-205. PubMed ID: 17605900
    [Abstract] [Full Text] [Related]

  • 31. Triamcinolone acetonide as adjunctive treatment to verteporfin in neovascular age-related macular degeneration: a prospective randomized trial.
    Chaudhary V, Mao A, Hooper PL, Sheidow TG.
    Ophthalmology; 2007 Dec; 114(12):2183-9. PubMed ID: 18054638
    [Abstract] [Full Text] [Related]

  • 32. Verteporfin plus ranibizumab for choroidal neovascularization in age-related macular degeneration: twelve-month results of the DENALI study.
    Kaiser PK, Boyer DS, Cruess AF, Slakter JS, Pilz S, Weisberger A, DENALI Study Group.
    Ophthalmology; 2012 May; 119(5):1001-10. PubMed ID: 22444829
    [Abstract] [Full Text] [Related]

  • 33. [Photodynamic therapy in age-related macular degeneration--results of one year observation].
    Wykrota H, Gierek-Łapińska A.
    Klin Oczna; 2002 May; 104(3-4):239-43. PubMed ID: 12608309
    [Abstract] [Full Text] [Related]

  • 34. Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization.
    Spaide RF, Sorenson J, Maranan L.
    Ophthalmology; 2005 Feb; 112(2):301-4. PubMed ID: 15691567
    [Abstract] [Full Text] [Related]

  • 35. Verteporfin therapy in age-related macular degeneration (VAM): an open-label multicenter photodynamic therapy study of 4,435 patients.
    Bessler NM, Vam Study Writing Committee.
    Retina; 2004 Aug; 24(4):512-20. PubMed ID: 15300071
    [Abstract] [Full Text] [Related]

  • 36. Photodynamic therapy with verteporfin following transpupillary thermotherapy for CNV evolving from an initially occult to a predominantly classic form, in patients with AMD.
    Hamon F, Goeminne P.
    Semin Ophthalmol; 2001 Dec; 16(4):223-32. PubMed ID: 15513445
    [Abstract] [Full Text] [Related]

  • 37. Selective photodynamic therapy for neovascular age-related macular degeneration with polypoidal choroidal neovascularization.
    Eandi CM, Ober MD, Freund KB, Slakter JS, Yannuzzi LA.
    Retina; 2007 Sep; 27(7):825-31. PubMed ID: 17891004
    [Abstract] [Full Text] [Related]

  • 38. One-year outcomes after photodynamic therapy in patients with age-related macular degeneration with poor baseline visual acuity.
    Potter MJ, Szabo SM.
    Graefes Arch Clin Exp Ophthalmol; 2006 Aug; 244(8):1026-8. PubMed ID: 16341540
    [Abstract] [Full Text] [Related]

  • 39. Factors influencing poor visual outcome in patients treated with photodynamic therapy for choroidal neovascularization secondary to age-related macular degeneration.
    Manku KK, Rotchford A, Whitaker J, Amoaku WM.
    Clin Exp Ophthalmol; 2007 Aug; 35(4):330-4. PubMed ID: 17539784
    [Abstract] [Full Text] [Related]

  • 40. Randomized multicenter trial of more intense and standard early verteporfin treatment of neovascular age-related macular degeneration.
    Schmidt-Erfurth U, Sacu S, Early Retreatment Study Group.
    Ophthalmology; 2008 Jan; 115(1):134-40. PubMed ID: 18166408
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.